Hypo-RESOLVE Investigates Hypoglycaemia and its Impact in Diabetes

Duration

Duration

48 months

Budget

Budget

€ 26.8 Mio

23 partners

23 partners

10 countries

About the project

Concept & Approach

News and Events

Intranet
Imprint
Privacy
Contact

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777460. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and T1D Exchange, JDRF, International Diabetes Federation (IDF), The Leona M. and Harry B. Helmsley Charitable Trust.